BChE-IN-8 structure
|
Common Name | BChE-IN-8 | ||
---|---|---|---|---|
CAS Number | 2653349-78-9 | Molecular Weight | 438.24 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C18H12BrN7O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of BChE-IN-8BChE-IN-8 (compound 20) is an orally active, potent and BBB-penetrated BChE (butyrylcholinesterase) inhibitor, with IC50 values of 0.15 nM (eqBChE, equine serum BChE) and 45.2 nM (hBChE), respectively. High stability of BChE-IN-8 contributes to significantly improved blood concentration and tissue exposure. BChE-IN-8 can exert neuro-protecting and cognition improving properties through multiple modulations, including cholinergic system, Aβ aggregation, neuropeptide levels. BChE-IN-8 can be used for Alzheimer's disease (AD) research[1]. |
Name | BChE-IN-8 |
---|
Description | BChE-IN-8 (compound 20) is an orally active, potent and BBB-penetrated BChE (butyrylcholinesterase) inhibitor, with IC50 values of 0.15 nM (eqBChE, equine serum BChE) and 45.2 nM (hBChE), respectively. High stability of BChE-IN-8 contributes to significantly improved blood concentration and tissue exposure. BChE-IN-8 can exert neuro-protecting and cognition improving properties through multiple modulations, including cholinergic system, Aβ aggregation, neuropeptide levels. BChE-IN-8 can be used for Alzheimer's disease (AD) research[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.15 ± 0.10 nM (eqBChE), 45.2 ± 45.0 nM (hBChE) [1] |
References |
Molecular Formula | C18H12BrN7O2 |
---|---|
Molecular Weight | 438.24 |